p_hc_order.doc

We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript.
You may experience difficulties browsing certain parts of the site.

Genzyme Corporate

Research

Genzyme Websites

About Thyrogen

Testing and Management

Ordering and Reimbursement

	Getting Started
	Guidelines and Forms
	Medicare Part B CAP

Resources

Prescribing Information (PDF)

ThyrogenONE

ThyrogenONE^SM is a new ordering and reimbursement services program for Thyrogen^® (thyrotropin alfa for injection). The ThyrogenONE program combines our expanded distribution network with centralized reimbursement services to make access to Thyrogen fast, simple and direct.

One Centralized System for all ordering and reimbursement support.

One Fax Form (PDF) and we’ll investigate your patients’ insurance benefits.

One Call for comprehensive support (1-88-THYROGEN).

One Network of specialty distributors with extensive payor contracts leading to assignment of benefits for many of your patients.

Register with the program to receive personalized service that makes access to Thyrogen convenient for you, your office staff and your patients.

Safety Information
Thyrogen® (thyrotropin alfa for injection) is indicated for use as an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine whole-body scan (WBS) in the follow-up of patients with well-differentiated thyroid cancer. It is a prescription product injected into the muscle. Thyrogen® may not be appropriate for all patients. The most commonly reported adverse events are headache, nausea, weakness and vomiting. Even with a Thyrogen®-stimulated Tg testing and WBS, a risk remains of missing a diagnosis of thyroid cancer or of underestimating the extent of disease. Adverse events should be reported promptly to Genzyme Medical Information at 1-800-745-4447. For more information on Thyrogen®, please see full prescribing information (PDF), contact the Medical Information department or contact Genzyme toll free at 1-88-THYROGEN (1-888-497-6436).


	Search Thyrogen
	Keyword:
	Search In:

Highlight

	Consider the Facts: Thyroid Cancer is the most common endocrine cancer and occurs in all age groups. Thyroid Cancer recently was ranked as the #1 cancer in incidence growth in women (National Cancer Institute data). Thyroid Cancer may recur in up to 30% of patients, even decades after initial diagnosis.

	Resources

	Request Clinical Information Patient Education Materials Request Materials Reconstitution Guide Product Monograph Related Links Testing Schedule Tg Lab Tracking Form Events Calendar Publications


	Contact Information

	Genzyme Therapeutics 500 Kendall Street Cambridge, MA 02142 888 497 6436 617 768 8050

	Contact Genzyme